SP-2011

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSP-2011
Drug Alias Namedual ETA/NFkB antagonist (PhytoPharmacon)SP-2011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsEndothelin receptor type A modulators
TargetsEndothelin receptor type ANuclear factor NF-kappa-B complex
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhytoPharmacon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhytoPharmacon Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A